Hikma Pharmaceuticals PLC Hikma Pharmaceuticals PLC

Hikma Pharmaceuticals PLC

HIK

Hisse Senetlerindeki Sıralama #25497
Hikma Pharmaceuticals PLC is a global pharmaceutical enterprise involved in the... Hikma Pharmaceuticals PLC is a global pharmaceutical enterprise involved in the creation, production, promotion, and distribution of a wide array of generic, branded, and licensed medicinal solutions. These offerings are presented in various dosage formats, including solid, semi-solid, liquid, and injectable forms. The company's operations are strategically structured into three core segments: Injectables, Generics, and Branded. The Injectables division specializes in providing generic injectable medications, predominantly for hospital environments. Conversely, the Generics segment is responsible for supplying oral and other non-injectable generic pharmaceuticals to the consumer retail market. The Branded unit caters to both retail and hospital clients with its proprietary generic and in-licensed products. Hikma's comprehensive product portfolio addresses a broad spectrum of medical conditions, including anti-infective, cardiovascular, central nervous system, diabetes, oncology, pain management, and respiratory ailments. The firm boasts a substantial international presence, conducting business across the United Kingdom, the United States, the Middle East, North Africa, and various European countries. Founded in 1978, the company's corporate headquarters are situated in London, United Kingdom.
Hisse Fiyatı
$22.49
Piyasa Değeri
$46.56M
Değişim (1 gün)
0.98%
Değişim (1 yıl)
-53.70%
Ülke
GB
Ticaret Hikma Pharmaceuticals PLC (HIK)

Kategori

Healthcare
Hikma Pharmaceuticals PLC (HIK) için hisse bölünme geçmişi
Hikma Pharmaceuticals PLC hissesi (sembol: HIK) toplamda 0 hisse bölünmesi yaşamıştır.
En son hisse bölünmesi Oct 21, 2026 tarihinde gerçekleşmiştir.
Oct 21, 2026 tarihinden önce alınan bir HIK hissesi bugün 0 HIK hissesine eşdeğerdir.
Hisse bölünme listesi
Yıl Bölünme Çarpan Kümülatif Çarpan
Sağlanan tarihler için yeterli veri yok.
Benzer şirketler veya rakipler için hisse bölünmeleri